Heron Therapeutics (HRTX) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Heron Therapeutics (HRTX) over the last 10 years, with Q3 2025 value amounting to -$2.1 million.
- Heron Therapeutics' Non Operating Income fell 42897.44% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.8 million, marking a year-over-year decrease of 14876.78%. This contributed to the annual value of -$2.1 million for FY2024, which is 46642.86% down from last year.
- Heron Therapeutics' Non Operating Income amounted to -$2.1 million in Q3 2025, which was down 42897.44% from -$744000.0 recorded in Q2 2025.
- In the past 5 years, Heron Therapeutics' Non Operating Income registered a high of $1.6 million during Q1 2024, and its lowest value of -$6.9 million during Q2 2022.
- For the 5-year period, Heron Therapeutics' Non Operating Income averaged around -$835500.0, with its median value being -$514500.0 (2024).
- In the last 5 years, Heron Therapeutics' Non Operating Income tumbled by 115659.34% in 2022 and then soared by 45525.42% in 2024.
- Quarter analysis of 5 years shows Heron Therapeutics' Non Operating Income stood at -$1.1 million in 2021, then surged by 143.82% to $486000.0 in 2022, then crashed by 116.26% to -$79000.0 in 2023, then plummeted by 545.57% to -$510000.0 in 2024, then plummeted by 304.51% to -$2.1 million in 2025.
- Its last three reported values are -$2.1 million in Q3 2025, -$744000.0 for Q2 2025, and -$519000.0 during Q1 2025.